belfasttelegraph Friday, 19 September, 2014

Gilead Sciences, Inc.

Gilead Sciences, Inc.

Search news from around the web

  1. Yesterday, RBC defended Gilead Sciences (GILD) after the failure of a drug trial for simtuzumab patients with pancreatic cancer. Today, Maxim’s Jason Kolbert leaps in to argue that the ... FULL ARTICLE AT Barron's

  2. Gilead drug fails in pancreatic cancer study

    One of Gilead Sciences Inc.'s first biologic drugs failed a mid-stage trial in tough-to-treat pancreatic cancer, the company said Wednesday. Simtuzumab, an experimental antibody that Foster City-based Gilead (NASDAQ ... FULL ARTICLE AT San Francisco Business Times

  1. On a day that’s seen the iShares Nasdaq Biotechnology ETF (IBB) rise, shares of Gilead Sciences (GILD) are falling after the biotech giant said a drug trial for the ... FULL ARTICLE AT Barron's

  2. Sept 17 (Reuters) - Over the last several months there has been a 'plateau and downward trend' in the use of Gilead Sciences Inc's controversial $1,000-a-pill hepatitis C treatment ... FULL ARTICLE AT Reuters

  3. In a Phase 2 clinical trial, Gilead Sciences' (GILD) lysyl oxidase-like-2 (LOXL2) inhibitor, simtuzumab, in combination with gemcitabine, fails to achieve its primary endpoint of increasing progression-free survival ((PFS)) compared ... FULL ARTICLE AT Seeking Alpha

  1. Gilead Sciences said Wednesday that results from a Phase 2 study showed its treatment simtuzumab didn't provide a clinical benefit in advanced pancreatic cancer patients. FULL ARTICLE AT OpinionJournal

  2. Sept 17 (Reuters) - Gilead Sciences Inc said its experimental drug did not significantly improve how long patients with a type of pancreatic cancer lived without the disease worsening. FULL ARTICLE AT Reuters

  3. Sept 17 (Reuters) - Gilead Sciences Inc said its experimental drug did not significantly improve the length of time that patients with a type of pancreatic cancer lived without the disease... FULL ARTICLE AT Reuters

  4. The signing of licensing agreement by US-based drug maker Gilead Sciences Inc for hepatitis C drug with seven India-based firms will give access to many patients to buy this medicine ... FULL ARTICLE AT Business Standard

About this topic

Wikipedia

Gilead Sciences (NASDAQ: GILD) is a biopharmaceutical company that discovers, develops and commercializes therapeutics. For many years since the company was founded, the company concentrated primarily on antiviral drugs to treat patients infected with HIV, hepatitis B or influenza. In 2006, Gilead acquired two companies that were developing drugs to treat patients with pulmonary diseases. The... Full Article At Wikipedia.org

Timeline of coverage

  1. Click to see all coverage from 2014-08-05
    2014-08-05
  2. Click to see all coverage from 2014-08-06
    2014-08-06
  3. Click to see all coverage from 2014-08-07
    2014-08-07
  4. Click to see all coverage from 2014-08-08
    2014-08-08
  5. Click to see all coverage from 2014-08-09
    2014-08-09
  6. Click to see all coverage from 2014-08-10
    2014-08-10
  7. Click to see all coverage from 2014-08-11
    2014-08-11
  8. Click to see all coverage from 2014-08-12
    2014-08-12
  9. Click to see all coverage from 2014-08-13
    2014-08-13
  10. Click to see all coverage from 2014-08-14
    2014-08-14
  11. Click to see all coverage from 2014-08-15
    2014-08-15
  12. Click to see all coverage from 2014-08-16
    2014-08-16
  13. Click to see all coverage from 2014-08-17
    2014-08-17
  14. Click to see all coverage from 2014-08-18
    2014-08-18
  15. Click to see all coverage from 2014-08-19
    2014-08-19
  16. Click to see all coverage from 2014-08-20
    2014-08-20
  17. Click to see all coverage from 2014-08-21
    2014-08-21
  18. Click to see all coverage from 2014-08-22
    2014-08-22
  19. Click to see all coverage from 2014-08-23
    2014-08-23
  20. Click to see all coverage from 2014-08-24
    2014-08-24
  21. Click to see all coverage from 2014-08-25
    2014-08-25
  22. Click to see all coverage from 2014-08-26
    2014-08-26
  23. Click to see all coverage from 2014-08-27
    2014-08-27
  24. Click to see all coverage from 2014-08-28
    2014-08-28
  25. Click to see all coverage from 2014-08-29
    2014-08-29
  26. Click to see all coverage from 2014-08-30
    2014-08-30
  27. Click to see all coverage from 2014-08-31
    2014-08-31
  28. Click to see all coverage from 2014-09-01
    2014-09-01
  29. Click to see all coverage from 2014-09-02
    2014-09-02
  30. Click to see all coverage from 2014-09-03
    2014-09-03
  31. Click to see all coverage from 2014-09-04
    2014-09-04
  32. Click to see all coverage from 2014-09-05
    2014-09-05
  33. Click to see all coverage from 2014-09-06
    2014-09-06
  34. Click to see all coverage from 2014-09-07
    2014-09-07
  35. Click to see all coverage from 2014-09-08
    2014-09-08
  36. Click to see all coverage from 2014-09-09
    2014-09-09
  37. Click to see all coverage from 2014-09-10
    2014-09-10
  38. Click to see all coverage from 2014-09-11
    2014-09-11
  39. Click to see all coverage from 2014-09-12
    2014-09-12
  40. Click to see all coverage from 2014-09-13
    2014-09-13
  41. Click to see all coverage from 2014-09-14
    2014-09-14
  42. Click to see all coverage from 2014-09-15
    2014-09-15
  43. Click to see all coverage from 2014-09-16
    2014-09-16
  44. Click to see all coverage from 2014-09-17
    2014-09-17
  45. Click to see all coverage from 2014-09-18
    2014-09-18
  46. Click to see all coverage from 2014-09-19
    2014-09-19

Login

Login to make editorial changes to the current page.

Login Cancel

Close